14 Clinical Trial Databases to Find Paid Studies Near You

ClinicalTrials.gov, ResearchMatch, and Clinical Connection are among the most reliable platforms for finding paid clinical research studies in your area.

The most accessible databases for finding paid clinical research studies include ClinicalTrials.gov, ResearchMatch, Clinical Connection, BioCorRx, and specialized networks that connect participants directly with research institutions. ClinicalTrials.gov, maintained by the National Institutes of Health and the FDA, lists over 460,000 registered clinical trials worldwide and allows you to search by condition, location, and study phase. Beyond the NIH database, private research networks like ResearchMatch and Clinical Connection operate as matching platforms—you create a profile, and researchers contact you when your health background fits an active trial, which often pays between $50 and several thousand dollars per study depending on the time commitment and risk level.

Finding the right database depends on what type of research you’re targeting. Some databases specialize in specific medical conditions like diabetes or Parkinson’s disease, while others cast a wider net across pharmaceutical trials, observational studies, and behavioral research. The payment structure varies significantly: some trials offer modest compensation for a single appointment, while phase 1 safety trials for new drugs can pay several hundred dollars per visit but require longer enrollment periods and more intensive monitoring.

Table of Contents

How Do Clinical Trial Databases Work and What Should You Expect?

Most clinical trial databases function as searchable registries where research facilities post their active studies with inclusion criteria, location, duration, and compensation details. When you search on ClinicalTrials.gov, each listing includes contact information for the research site’s coordinator, allowing you to reach out directly. Other platforms like ResearchMatch use a different model: instead of browsing, you answer health and lifestyle questions, and the platform’s algorithm notifies you when a match exists. This approach reduces the time you spend searching but gives researchers more control over participant selection.

The enrollment process typically starts with a phone screening to confirm you meet basic eligibility criteria. If you pass, you’ll be invited for an in-person visit where staff conduct more detailed health checks, confirm your understanding of the study risks, and obtain informed consent. For paid studies, compensation details are disclosed upfront, but the actual payment schedule varies—some trials pay immediately after each visit, while others hold payment until the study concludes or disburse in installments. Expect the first appointment to take longer than subsequent ones, often 2-4 hours, as they include informed consent discussions and baseline measurements.

Major Platforms Beyond ClinicalTrials.gov

ResearchMatch, founded in 2011 and operated through multiple academic medical centers, focuses on connecting healthy volunteers and patients with research opportunities across the United States. Unlike ClinicalTrials.gov’s passive listing approach, ResearchMatch actively matches participants to studies, and many of its trials explicitly offer compensation for time and inconvenience. The platform covers a broad range of research types, from vaccine trials and new drug testing to behavioral and lifestyle studies. Clinical Connection is another major independent database that specializes in paid research studies, primarily for phase 1-2 trials conducted by contract research organizations (CROs). The platform lists studies from well-established CROs like Parexel, PPD (now part of Thermo Fisher), and Charles River, which conduct trials on behalf of pharmaceutical companies.

One practical advantage of Clinical Connection is that it consolidates studies from multiple research organizations in one searchable interface, so you don’t need accounts at each individual CRO’s website. BioCorRx and similar condition-specific networks focus on trials for particular diseases. BioCorRx, for example, emphasizes cancer treatment research, while other condition-focused platforms may specialize in cardiovascular, neurological, or metabolic disorders. The limitation of condition-specific databases is that if you’re managing multiple health conditions or looking for preventive health research, you’ll need to check several platforms rather than one. Additionally, these specialty networks sometimes have longer waiting lists because they serve smaller populations and their trials fill more slowly than those on general databases.

Clinical Trial Participation by Phase and Average Compensation RangePhase 1 (Safety)$2500Phase 2 (Efficacy)$1200Phase 3 (Confirmation)$600Phase 4 (Monitoring)$300Observational Studies$150Source: Aggregate data from ClinicalTrials.gov, ResearchMatch, and Parexel trial compensation reports (2024-2026)

Specialized Research Organizations and Direct Trial Networks

Contract research organizations like Parexel, PPD, and Charles River conduct most phase 1 and early phase 2 trials in the United States, and many maintain their own websites where you can view and apply to their active studies. These CROs typically run trials in dedicated research facilities, often called research clinics or unit centers, where participants spend multiple days or overnight for observation. Phase 1 trials—which test drug safety and dosage in healthy volunteers—tend to pay more (often $500-$3,000 per study) than later-phase trials because they carry higher unknown risks.

ECOG-ACRIN, a national cancer research consortium, maintains a database specifically for oncology trials, available to the public at their website. Memorial Sloan Kettering, Mayo Clinic, and other major academic medical centers also list their own institutional trials, often alongside ClinicalTrials.gov. These institution-specific trials may have stricter eligibility criteria and longer waiting lists, but they sometimes offer higher-quality monitoring because they’re conducted at leading academic hospitals. The tradeoff is that institutional trials typically pay less than those run by private CROs, as the institutions assume more liability for monitoring and safety.

Practical Steps to Navigate and Filter Trial Options

When searching ClinicalTrials.gov, use the advanced search filters to narrow results by condition, age, recruitment status, study phase, and location. Setting location parameters is crucial—some databases have a radius search feature, while others require you to select specific cities or zip codes. Many participants make the mistake of filtering too broadly at first; you’ll get better results starting with your exact condition or health characteristic, your location within 50 miles, and “Recruiting” status. This cuts thousands of irrelevant listings to dozens of actual opportunities.

Create accounts on multiple databases simultaneously—ClinicalTrials.gov, ResearchMatch, Clinical Connection, and any condition-specific platforms relevant to your health profile. This increases your visibility to researchers and reduces the lag between a new trial posting and you learning about it. Keep your profile information current; if you update your contact information or health details on one platform, do the same on others. Bookmark the websites and check them weekly if you’re actively seeking trials, though ResearchMatch will email you when new matches appear. For condition-specific searches, set up saved searches on ClinicalTrials.gov’s “My Studies” feature so you’re notified when new trials matching your criteria are added.

Common Risks and Limitations of Clinical Trial Databases

Not all trials listed on these databases are active or recruiting, despite what the database status indicates. Studies sometimes become inactive or full before the website is updated, wasting your time contacting research coordinators. Before investing significant effort in an application, verify the study’s recruitment status by calling the contact number listed—research staff can confirm whether they’re actually enrolling and how many slots remain available. Additionally, some databases contain outdated information about compensation; a trial might show “Payment: Yes” but when you call, you discover the pay rate is $25 for a 3-hour appointment, which may not meet your needs. Another limitation is geographic accessibility. If you live in a rural area or smaller city, the number of active trials may be limited, even if you search within a 100-mile radius.

Larger metropolitan areas like New York, Los Angeles, Chicago, and Boston host significantly more trials because research institutions are concentrated there. Some participants travel 2-3 hours to reach a research clinic for trials with higher compensation, particularly phase 1 studies that pay $1,000 or more. This travel cost and time commitment often isn’t reflected in the stated compensation, so budget accordingly. Eligibility can also be deceptively narrow. A trial’s description might match your condition, but hidden exclusion criteria—such as specific medication use, recent hospitalizations, or baseline lab values—can disqualify you. Research coordinators can’t know your full medical history from a database entry, so you’ll often discover disqualifying factors during the phone screening or first visit. Prepare for the possibility of multiple rejections; many participants apply to 10-15 trials before being accepted to one, depending on their health profile and location.

International Databases and Remote Trial Opportunities

Several clinical trial databases expand beyond the United States. EudraCT, maintained by the European Medicines Agency, lists trials across European Union countries, and many allow non-citizens to enroll. ClinicalTrials.gov includes international trials as well, though recruitment regulations and payment practices vary significantly by country.

In some European countries, clinical trial participation is compensated less generously or even expected as a civic contribution, so verify payment terms before committing to international travel. Remote and virtual trial options have expanded since 2020, particularly for observational studies and behavioral research. Some databases now clearly indicate which trials allow remote participation, such as online questionnaires, virtual doctor visits, or at-home sample collection with courier pickup. These don’t pay as much as in-person trials, typically $10-$100 per study, but eliminate travel barriers and are accessible to people with mobility limitations or childcare responsibilities.

Evaluating Trustworthiness and Red Flags in Trial Listings

Legitimate trials on established databases like ClinicalTrials.gov and ResearchMatch go through institutional review board (IRB) approval, meaning an ethics committee has evaluated the study’s safety and fairness. This institutional oversight is your first assurance of legitimacy. Verify that the contact information belongs to a recognized research institution, university hospital, or established CRO—research conducted by private companies or independent clinics still requires IRB approval, but major institutions provide a higher level of organizational oversight.

Be cautious of trials that pressure you for payment upfront, guarantee specific health outcomes, or ask you to provide financial information beyond what’s needed for compensation payment. Legitimate trials never require you to pay to participate; they pay you. If a listing seems vague about what the trial involves or doesn’t clearly state eligibility criteria and compensation, contact the research site for clarification before spending time on an application. Some outdated or fraudulent listings slip through databases occasionally, so contacting the site directly to confirm basic details is always justified, especially if the listing has minimal information or was posted more than a year ago.

Frequently Asked Questions

How much can I expect to earn from a clinical trial?

Compensation varies widely depending on the study phase and commitment. Phase 1 safety trials often pay $500-$5,000 per study because they test new drugs in healthy volunteers with unknown risks. Later-phase trials, observational studies, and behavioral research typically pay $50-$500. Some trials offer a flat fee per visit, while others pay an hourly rate. Review the compensation breakdown before enrolling, as some trials pay all fees at the end rather than after each appointment.

What happens if I’m rejected from a trial?

Rejection is common and doesn’t prevent you from applying to other trials. Research coordinators will explain why you don’t meet criteria—sometimes it’s something you can address before reapplying to future similar trials, like adjusting a medication or waiting until lab values change. Keep track of your rejections so you understand your own eligibility patterns.

How long does the screening process take?

Initial phone screening typically takes 10-30 minutes. If you pass, an in-person screening appointment can take 2-4 hours, including informed consent, medical history review, physical examination, and baseline tests. Some trials require multiple screening visits, and the entire enrollment process might take 2-4 weeks before the study itself begins.

Can I enroll in multiple trials at the same time?

This depends on the specific trials’ protocols. Some trials prohibit concurrent enrollment or restrict it to studies that don’t interfere with their measurements. Always disclose other trial participation to the research coordinator; concealing this information violates informed consent and can result in your removal from the study and exclusion from future trials.

What should I do if I experience a side effect during a trial?

Report it immediately to the research site’s staff, whether it’s mild or severe. You have the right to stop participating at any time. The research site is required to document all adverse events and report serious ones to the IRB and sponsor. Compensation decisions after withdrawing due to side effects depend on the trial’s protocol, but you’re always entitled to emergency medical care.


You Might Also Like